Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VTC

Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK3

3VTC の概要
エントリーDOI10.2210/pdb3vtc/pdb
関連するPDBエントリー2ZLC 3VTB 3VTD
分子名称Vitamin D3 receptor, COACTIVATOR PEPTIDE DRIP, (1R,3R,7E,17beta)-17-{(2R,6R)-6-hydroxy-7-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]hept-4-yn-2-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol, ... (5 entities in total)
機能のキーワードtranscription, hormone receptor
由来する生物種Rattus norvegicus (rats)
詳細
細胞内の位置Nucleus: P13053
タンパク質・核酸の鎖数2
化学式量合計32760.80
構造登録者
Nakabayashi, M.,Kudo, T.,Tokiwa, H.,Makishima, M.,Yamada, S.,Ikura, T.,Ito, N. (登録日: 2012-05-26, 公開日: 2013-06-12, 最終更新日: 2023-11-08)
主引用文献Kudo, T.,Ishizawa, M.,Maekawa, K.,Nakabayashi, M.,Watarai, Y.,Uchida, H.,Tokiwa, H.,Ikura, T.,Ito, N.,Makishima, M.,Yamada, S.
Combination of Triple Bond and Adamantane Ring on the Vitamin D Side Chain Produced Partial Agonists for Vitamin D Receptor.
J.Med.Chem., 2014
Cited by
PubMed Abstract: Vitamin D receptor (VDR) ligands are therapeutic agents that are used for the treatment of psoriasis, osteoporosis, and secondary hyperparathyroidism and have immense potential as therapeutic agents for autoimmune diseases, cancers, and cardiovascular diseases. However, the major side effect of VDR ligands, the development of hypercalcemia, limits their expanded use. To develop tissue-selective VDR modulators, we have designed vitamin D analogues with an adamantane ring at the side chain terminal, which would interfere with helix 12, the activation function 2, and modulate the VDR potency. Here we report 25- or 26-adamantyl-23,23,24,24-tetradehydro-19-norvitamin D derivatives (ADTK1-4, 4b,a and 5a,b). These compounds showed high VDR affinities (90% at maximum), partial agonistic activities (EC50 10(-9)-10(-8) M with 40-80% efficacy) in transactivation, and tissue-selective activity in target gene expressions. We investigate the structure-activity relationships of these compounds on the basis of their X-ray crystal structures.
PubMed: 24773565
DOI: 10.1021/jm401989c
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.5 Å)
構造検証レポート
Validation report summary of 3vtc
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon